NuCana Presents Preclinical Data Showing NUC-7738 Enhances Carfilzomib Activity in Multiple Myeloma Cell Lines at the 38th EORTC-NCI-AACR Symposium
NUC-7738 Increased Proteasome Inhibition When Combined with Carfilzomib Data Presented Identify an Additional Potential Mode of Action for NUC-7738 and Support Evaluation of Additional Indications and Combination Strategies BARCELONA, Spain, Nov.